Skip to content
Menu

The Precision Peptide Company Inc. PNGAF

Full chart Compare
Set alert

Price alert · PNGAF

All alert types
0.17 USD 0.00 (+0.58%)

Regular-session close

0.162 Day range 0.1664
0.0077 52-week range 0.4099
YTD
-15.36%
1 year
-25.02%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-3.96 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.9×
P/S 177×
P/B 9.4×
P/FCF -3.8×
EV/EBITDA -3.6×
EV/Sales 157×
FCF Yield -26.5%

Profitability

Gross Margin -139.1%
Operating Margin -4530.1%
Net Margin -9104.5%
ROE -486.9%
ROIC -242.3%
ROA -340.1%

Growth (YoY)

Revenue 307.4%
Operating Income -144.6%
EPS (diluted) -40.0%
Free Cash Flow -429.9%

Financial Health

Current Ratio 3.3×
Quick Ratio 3.1×
Debt / Equity 0.0×
Net Debt / EBITDA 0.4×
Interest Coverage 0.0×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-10-31